Biointaxis is a company headquartered in Spain.
Biointaxis is a biotech academic spin-off developing gene therapy treatments for rare genetic diseases, specifically focusing on Friedreich's ataxia, and aims to license its products to pharmaceutical partners.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.